Dean Y. Li - Apr 3, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2023, 06:00 PM
Previous filing
Jan 25, 2023
Next filing
Oct 4, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.72K +0.28% $0.00 623K Apr 3, 2023 Direct F1
holding RXRX Class A Common Stock 1.32M Apr 3, 2023 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.42M Apr 3, 2023 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 450K Apr 3, 2023 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.